Cardlytics Statistics
Share Statistics
Cardlytics has 50.82M shares outstanding. The number of shares has increased by 26.97% in one year.
| Shares Outstanding | 50.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 2.17% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 48.32M |
| Failed to Deliver (FTD) Shares | 317 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 7.10M, so 13.96% of the outstanding shares have been sold short.
| Short Interest | 7.10M |
| Short % of Shares Out | 13.96% |
| Short % of Float | 14.7% |
| Short Ratio (days to cover) | 11.41 |
Valuation Ratios
The PE ratio is -2.49 and the forward PE ratio is -12.44.
| PE Ratio | -2.49 |
| Forward PE | -12.44 |
| PS Ratio | 1.09 |
| Forward PS | 0.7 |
| PB Ratio | 2.49 |
| P/FCF Ratio | -26.72 |
| PEG Ratio | n/a |
Enterprise Valuation
Cardlytics Inc. has an Enterprise Value (EV) of 510.33M.
| EV / Earnings | -3.79 |
| EV / Sales | 1.65 |
| EV / EBITDA | -5.15 |
| EV / EBIT | -3.76 |
| EV / FCF | -40.58 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 1.91.
| Current Ratio | 1.31 |
| Quick Ratio | 1.31 |
| Debt / Equity | 1.91 |
| Total Debt / Capitalization | 65.65 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -21.94 |
Financial Efficiency
Return on equity (ROE) is -1% and return on capital (ROIC) is -33.84%.
| Return on Equity (ROE) | -1% |
| Return on Assets (ROA) | -0.23% |
| Return on Capital (ROIC) | -33.84% |
| Revenue Per Employee | 678.08K |
| Profits Per Employee | -295.40K |
| Employee Count | 456 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -57.08% in the last 52 weeks. The beta is 1.62, so Cardlytics 's price volatility has been higher than the market average.
| Beta | 1.62 |
| 52-Week Price Change | -57.08% |
| 50-Day Moving Average | 3.87 |
| 200-Day Moving Average | 7.37 |
| Relative Strength Index (RSI) | 42.1 |
| Average Volume (20 Days) | 748.87K |
Income Statement
In the last 12 months, Cardlytics had revenue of $309.20M and earned -$134.70M in profits. Earnings per share was $-3.69.
| Revenue | 309.20M |
| Gross Profit | 130.38M |
| Operating Income | -135.67M |
| Net Income | -134.70M |
| EBITDA | -99.00M |
| EBIT | -135.67M |
| Earnings Per Share (EPS) | -3.69 |
Balance Sheet
The company has $91.83M in cash and $266.11M in debt, giving a net cash position of -$174.28M.
| Cash & Cash Equivalents | 91.83M |
| Total Debt | 266.11M |
| Net Cash | -174.28M |
| Retained Earnings | -1.11B |
| Total Assets | 399.39M |
| Working Capital | 27.42M |
Cash Flow
In the last 12 months, operating cash flow was -$185.00K and capital expenditures -$12.39M, giving a free cash flow of -$12.58M.
| Operating Cash Flow | -185.00K |
| Capital Expenditures | -12.39M |
| Free Cash Flow | -12.58M |
| FCF Per Share | -0.34 |
Margins
Gross margin is 42.17%, with operating and profit margins of -43.88% and -43.56%.
| Gross Margin | 42.17% |
| Operating Margin | -43.88% |
| Pretax Margin | -43.56% |
| Profit Margin | -43.56% |
| EBITDA Margin | -32.02% |
| EBIT Margin | -43.88% |
| FCF Margin | -4.07% |
Dividends & Yields
CDLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -99.73% |
| FCF Yield | -6.69% |
Analyst Forecast
The average price target for CDLX is $4.5, which is 21.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.5 |
| Price Target Difference | 21.6% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
Scores
| Altman Z-Score | -5.53 |
| Piotroski F-Score | 4 |